| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANTARES PHARMA, INC. | Director | Common Stock | 0 | $5.60 | May 24, 2022 | Direct | |
| ANTARES PHARMA, INC. | Director | Stock Option (right to buy) | 0 | May 24, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATRS | ANTARES PHARMA, INC. | May 24, 2022 | 11 | -$940K | 4 | May 26, 2022 | Director |
| ATRS | ANTARES PHARMA, INC. | Jun 10, 2021 | 2 | $112K | 4 | Jun 14, 2021 | Director |